Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "024445-2025",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 4,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "6",
"value": 3,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "11",
"value": 3,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "16",
"value": 3,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "21",
"value": 3,
"measure": "bids",
"relatedLot": "5"
},
{
"id": "26",
"value": 6,
"measure": "bids",
"relatedLot": "6"
},
{
"id": "2",
"value": 4,
"measure": "smeBids",
"relatedLot": "1"
},
{
"id": "7",
"value": 3,
"measure": "smeBids",
"relatedLot": "2"
},
{
"id": "12",
"value": 3,
"measure": "smeBids",
"relatedLot": "3"
},
{
"id": "17",
"value": 3,
"measure": "smeBids",
"relatedLot": "4"
},
{
"id": "22",
"value": 3,
"measure": "smeBids",
"relatedLot": "5"
},
{
"id": "27",
"value": 6,
"measure": "smeBids",
"relatedLot": "6"
},
{
"id": "3",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "1"
},
{
"id": "8",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "2"
},
{
"id": "13",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "3"
},
{
"id": "18",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "4"
},
{
"id": "23",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "5"
},
{
"id": "28",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "6"
},
{
"id": "4",
"value": 4,
"measure": "foreignBidsFromNonEU",
"relatedLot": "1"
},
{
"id": "9",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "2"
},
{
"id": "14",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "3"
},
{
"id": "19",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "4"
},
{
"id": "24",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "5"
},
{
"id": "29",
"value": 6,
"measure": "foreignBidsFromNonEU",
"relatedLot": "6"
},
{
"id": "5",
"value": 4,
"measure": "electronicBids",
"relatedLot": "1"
},
{
"id": "10",
"value": 3,
"measure": "electronicBids",
"relatedLot": "2"
},
{
"id": "15",
"value": 3,
"measure": "electronicBids",
"relatedLot": "3"
},
{
"id": "20",
"value": 3,
"measure": "electronicBids",
"relatedLot": "4"
},
{
"id": "25",
"value": 3,
"measure": "electronicBids",
"relatedLot": "5"
},
{
"id": "30",
"value": 6,
"measure": "electronicBids",
"relatedLot": "6"
}
]
},
"date": "2025-05-22T09:01:43+01:00",
"ocid": "ocds-h6vhtk-0489eb",
"buyer": {
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774949"
}
],
"awards": [
{
"id": "024445-2025-1",
"title": "Water Testing (Glasgow Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148956",
"name": "Assured Micro Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "024445-2025-2",
"title": "RNA Therapeutic/Vaccines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
}
],
"relatedLots": [
"2"
]
},
{
"id": "024445-2025-3",
"title": "Recombinant Protein Therapeutics",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
}
],
"relatedLots": [
"3"
]
},
{
"id": "024445-2025-4",
"title": "Process and Product Microbiology (Teesside Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "024445-2025-5",
"title": "Process and Product Microbiology (Glasgow Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148961",
"name": "Assured Micro"
}
],
"relatedLots": [
"5"
]
},
{
"id": "024445-2025-6",
"title": "Oligonucleotides",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148962",
"name": "CatSci Ltd"
}
],
"relatedLots": [
"6"
]
}
],
"tender": {
"id": "3345",
"lots": [
{
"id": "2",
"title": "RNA Therapeutic/Vaccines",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington currently manufactures RNA-LNP vaccines and therapeutics for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for RNA-LNP analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for RNA In-process samples, RNA-LNP drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for RNA-LNP drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "- Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "3",
"title": "Recombinant Protein Therapeutics",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington will, in the future, manufacture Recombinant protein vaccines and therapeutics produced in Microbial cell lines, for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for Recombinant Protein analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for Recombinant Protein drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for Recombinant Protein drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "4",
"title": "Process and Product Microbiology (Teesside Area)",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington will require Microbiology testing to support the RNA-LNP and Recombinant Protein GMP manufacture.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Buffers)\n-\tEndotoxin (Process product Protein)\n-\tEndotoxin (Process product RNA and RNA-LNP)\n-\tBioburden (Buffers)\n-\tBioburden (Process product Protein)\n-\tBioburden (Process product RNA and RNA-LNP)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "5",
"title": "Process and Product Microbiology (Glasgow Area)",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Glasgow will require Microbiology testing to support the GMP manufacturing of oligonucleotide therapies.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Process product oligonucleotide)\n-\tBioburden (Process product oligonucleotide)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "6",
"title": "Oligonucleotides",
"status": "cancelled",
"hasOptions": false,
"description": "The facility at MMIC will manufacture both single and double stranded novel oligonucleotides for early phase clinical trials. The drug substance (API) may be a lyophilised powder or solution API and the finished drug product may be a solid or liquid formulation.\nThe requirements for oligonucleotides analysis include:\n-\tChemical analysis for oligonucleotide drug substance and drug product (release and stability analysis)\n-\tMethod development, verification and phase appropriate validation (as required)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "1",
"title": "Water Testing (Glasgow Area)",
"status": "cancelled",
"hasOptions": false,
"description": "The MMIC facility near Glasgow will require microbiological testing of water samples in accordance with Ph. Eur. [0169]. The following analysis techniques are required and have been included in pricing schedule for comparison:\n-Microbiological monitoring (Ph. Eur.)\n-Bacterial endotoxin testing (Ph. Eur.)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
}
],
"items": [
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "6",
"relatedLot": "6",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
}
],
"title": "Framework for QC Analytical Testing Requirements",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "You are invited to submit a tender for the following requirements; analytical services for multiple modalities drug substances and drug products required for early phase clinical trials. This tender is to cover the analytical services required for release analysis of drug substance (DS) and drug product (DP).",
"classification": {
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
},
"procurementMethod": "open",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UK",
"locality": "Redcar",
"postalCode": "TS10 4RF",
"countryName": "United Kingdom",
"streetAddress": "Wilton Centre"
},
"details": {
"url": "http://www.uk-cpi.com",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA30305",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"description": "Research And Development"
}
]
},
"identifier": {
"legalName": "Centre for Process Innovation Limited"
},
"contactPoint": {
"name": "E-Tendering",
"email": "e-tendering@uk-cpi.com",
"telephone": "+44 1642455340"
}
},
{
"id": "GB-FTS-148956",
"name": "Assured Micro Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKM82",
"locality": "Glasgow",
"postalCode": "G20 0SP",
"countryName": "United Kingdom",
"streetAddress": "West of Scotland Science Park, Block 6, Kelvin Campus"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Assured Micro Ltd"
},
"contactPoint": {
"faxNumber": "+44 1419464545",
"telephone": "+44 1419464545"
}
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Manchester",
"postalCode": "M1 2PW",
"countryName": "United Kingdom",
"streetAddress": "Bainbridge House, 86-90 London Road"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
"contactPoint": {
"telephone": "+44 1619334000"
}
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Ellesmere Port",
"postalCode": "CH65 3EN",
"countryName": "United Kingdom",
"streetAddress": "Rossmore Industrial Estate"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "SGS UK Ltd"
},
"contactPoint": {
"telephone": "+44 7734058857"
}
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Reading",
"postalCode": "Rg6 6LA",
"countryName": "United Kingdom",
"streetAddress": "Reading Science Centre , Whiteknights Campus, Pepper Lane"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Reading Scientific Serices Ltd"
},
"contactPoint": {
"telephone": "+44 0118918400"
},
"additionalContactPoints": [
{
"faxNumber": "+44 0118918400",
"telephone": "+44 0118918400"
}
]
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Gosport",
"postalCode": "PO130AU",
"countryName": "United Kingdom",
"streetAddress": "Hoeford Point, Barwell Lane"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Wickham Micro Ltd"
},
"contactPoint": {
"telephone": "+44 7975959256"
}
},
{
"id": "GB-FTS-148961",
"name": "Assured Micro",
"roles": [
"supplier"
],
"address": {
"region": "UKM82",
"locality": "Glasgow",
"postalCode": "G20 0SP",
"countryName": "United Kingdom",
"streetAddress": "Block 6 Kelvin Campus, West Scotland Science Park"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Assured Micro"
},
"contactPoint": {
"telephone": "+44 1419464545"
}
},
{
"id": "GB-FTS-148962",
"name": "CatSci Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKL22",
"locality": "Cardiff",
"postalCode": "CF64 5TH",
"countryName": "United Kingdom",
"streetAddress": "CBTC2, CBTC2, Capital Business Park, Wentloog,"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "CatSci Ltd"
},
"contactPoint": {
"telephone": "+44 7799286698"
}
},
{
"id": "GB-FTS-78625",
"name": "Glasgow Sheriff & Justice of the Peace Court",
"roles": [
"reviewBody"
],
"address": {
"locality": "Glasgow",
"postalCode": "G5 9DA",
"countryName": "United Kingdom",
"streetAddress": "Sheriff Clerk's Office, 1 Carlton Place"
},
"identifier": {
"legalName": "Glasgow Sheriff & Justice of the Peace Court"
}
}
],
"language": "en",
"contracts": [
{
"id": "024445-2025-1",
"title": "Water Testing (Glasgow Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-1",
"dateSigned": "2025-03-04T00:00:00Z"
},
{
"id": "024445-2025-2",
"title": "RNA Therapeutic/Vaccines",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-2",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-3",
"title": "Recombinant Protein Therapeutics",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-3",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-4",
"title": "Process and Product Microbiology (Teesside Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-4",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-5",
"title": "Process and Product Microbiology (Glasgow Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-5",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-6",
"title": "Oligonucleotides",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-6",
"dateSigned": "2025-04-28T00:00:00+01:00"
}
],
"description": "(SC Ref:797494)",
"initiationType": "tender"
}Complete JSON history (2 releases)
22 May 2025 · 024445-2025 · award, contract
{
"id": "024445-2025",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 4,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "6",
"value": 3,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "11",
"value": 3,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "16",
"value": 3,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "21",
"value": 3,
"measure": "bids",
"relatedLot": "5"
},
{
"id": "26",
"value": 6,
"measure": "bids",
"relatedLot": "6"
},
{
"id": "2",
"value": 4,
"measure": "smeBids",
"relatedLot": "1"
},
{
"id": "7",
"value": 3,
"measure": "smeBids",
"relatedLot": "2"
},
{
"id": "12",
"value": 3,
"measure": "smeBids",
"relatedLot": "3"
},
{
"id": "17",
"value": 3,
"measure": "smeBids",
"relatedLot": "4"
},
{
"id": "22",
"value": 3,
"measure": "smeBids",
"relatedLot": "5"
},
{
"id": "27",
"value": 6,
"measure": "smeBids",
"relatedLot": "6"
},
{
"id": "3",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "1"
},
{
"id": "8",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "2"
},
{
"id": "13",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "3"
},
{
"id": "18",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "4"
},
{
"id": "23",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "5"
},
{
"id": "28",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "6"
},
{
"id": "4",
"value": 4,
"measure": "foreignBidsFromNonEU",
"relatedLot": "1"
},
{
"id": "9",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "2"
},
{
"id": "14",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "3"
},
{
"id": "19",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "4"
},
{
"id": "24",
"value": 3,
"measure": "foreignBidsFromNonEU",
"relatedLot": "5"
},
{
"id": "29",
"value": 6,
"measure": "foreignBidsFromNonEU",
"relatedLot": "6"
},
{
"id": "5",
"value": 4,
"measure": "electronicBids",
"relatedLot": "1"
},
{
"id": "10",
"value": 3,
"measure": "electronicBids",
"relatedLot": "2"
},
{
"id": "15",
"value": 3,
"measure": "electronicBids",
"relatedLot": "3"
},
{
"id": "20",
"value": 3,
"measure": "electronicBids",
"relatedLot": "4"
},
{
"id": "25",
"value": 3,
"measure": "electronicBids",
"relatedLot": "5"
},
{
"id": "30",
"value": 6,
"measure": "electronicBids",
"relatedLot": "6"
}
]
},
"date": "2025-05-22T09:01:43+01:00",
"ocid": "ocds-h6vhtk-0489eb",
"buyer": {
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774949"
}
],
"awards": [
{
"id": "024445-2025-1",
"title": "Water Testing (Glasgow Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148956",
"name": "Assured Micro Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "024445-2025-2",
"title": "RNA Therapeutic/Vaccines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
}
],
"relatedLots": [
"2"
]
},
{
"id": "024445-2025-3",
"title": "Recombinant Protein Therapeutics",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
}
],
"relatedLots": [
"3"
]
},
{
"id": "024445-2025-4",
"title": "Process and Product Microbiology (Teesside Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "024445-2025-5",
"title": "Process and Product Microbiology (Glasgow Area)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd"
},
{
"id": "GB-FTS-148961",
"name": "Assured Micro"
}
],
"relatedLots": [
"5"
]
},
{
"id": "024445-2025-6",
"title": "Oligonucleotides",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd"
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
{
"id": "GB-FTS-148962",
"name": "CatSci Ltd"
}
],
"relatedLots": [
"6"
]
}
],
"tender": {
"id": "3345",
"lots": [
{
"id": "2",
"title": "RNA Therapeutic/Vaccines",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington currently manufactures RNA-LNP vaccines and therapeutics for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for RNA-LNP analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for RNA In-process samples, RNA-LNP drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for RNA-LNP drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "- Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "3",
"title": "Recombinant Protein Therapeutics",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington will, in the future, manufacture Recombinant protein vaccines and therapeutics produced in Microbial cell lines, for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for Recombinant Protein analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for Recombinant Protein drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for Recombinant Protein drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "4",
"title": "Process and Product Microbiology (Teesside Area)",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Darlington will require Microbiology testing to support the RNA-LNP and Recombinant Protein GMP manufacture.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Buffers)\n-\tEndotoxin (Process product Protein)\n-\tEndotoxin (Process product RNA and RNA-LNP)\n-\tBioburden (Buffers)\n-\tBioburden (Process product Protein)\n-\tBioburden (Process product RNA and RNA-LNP)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "5",
"title": "Process and Product Microbiology (Glasgow Area)",
"status": "cancelled",
"hasOptions": false,
"description": "Our facility in Glasgow will require Microbiology testing to support the GMP manufacturing of oligonucleotide therapies.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Process product oligonucleotide)\n-\tBioburden (Process product oligonucleotide)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "6",
"title": "Oligonucleotides",
"status": "cancelled",
"hasOptions": false,
"description": "The facility at MMIC will manufacture both single and double stranded novel oligonucleotides for early phase clinical trials. The drug substance (API) may be a lyophilised powder or solution API and the finished drug product may be a solid or liquid formulation.\nThe requirements for oligonucleotides analysis include:\n-\tChemical analysis for oligonucleotide drug substance and drug product (release and stability analysis)\n-\tMethod development, verification and phase appropriate validation (as required)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
},
{
"id": "1",
"title": "Water Testing (Glasgow Area)",
"status": "cancelled",
"hasOptions": false,
"description": "The MMIC facility near Glasgow will require microbiological testing of water samples in accordance with Ph. Eur. [0169]. The following analysis techniques are required and have been included in pricing schedule for comparison:\n-Microbiological monitoring (Ph. Eur.)\n-Bacterial endotoxin testing (Ph. Eur.)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
}
}
],
"items": [
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "6",
"relatedLot": "6",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
}
],
"title": "Framework for QC Analytical Testing Requirements",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "You are invited to submit a tender for the following requirements; analytical services for multiple modalities drug substances and drug products required for early phase clinical trials. This tender is to cover the analytical services required for release analysis of drug substance (DS) and drug product (DP).",
"classification": {
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
},
"procurementMethod": "open",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UK",
"locality": "Redcar",
"postalCode": "TS10 4RF",
"countryName": "United Kingdom",
"streetAddress": "Wilton Centre"
},
"details": {
"url": "http://www.uk-cpi.com",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA30305",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"description": "Research And Development"
}
]
},
"identifier": {
"legalName": "Centre for Process Innovation Limited"
},
"contactPoint": {
"name": "E-Tendering",
"email": "e-tendering@uk-cpi.com",
"telephone": "+44 1642455340"
}
},
{
"id": "GB-FTS-148956",
"name": "Assured Micro Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKM82",
"locality": "Glasgow",
"postalCode": "G20 0SP",
"countryName": "United Kingdom",
"streetAddress": "West of Scotland Science Park, Block 6, Kelvin Campus"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Assured Micro Ltd"
},
"contactPoint": {
"faxNumber": "+44 1419464545",
"telephone": "+44 1419464545"
}
},
{
"id": "GB-FTS-148957",
"name": "ITS Testing Services (UK) Ltd trading as Intertek P&IA",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Manchester",
"postalCode": "M1 2PW",
"countryName": "United Kingdom",
"streetAddress": "Bainbridge House, 86-90 London Road"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "ITS Testing Services (UK) Ltd trading as Intertek P&IA"
},
"contactPoint": {
"telephone": "+44 1619334000"
}
},
{
"id": "GB-FTS-148958",
"name": "SGS UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Ellesmere Port",
"postalCode": "CH65 3EN",
"countryName": "United Kingdom",
"streetAddress": "Rossmore Industrial Estate"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "SGS UK Ltd"
},
"contactPoint": {
"telephone": "+44 7734058857"
}
},
{
"id": "GB-FTS-148959",
"name": "Reading Scientific Serices Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Reading",
"postalCode": "Rg6 6LA",
"countryName": "United Kingdom",
"streetAddress": "Reading Science Centre , Whiteknights Campus, Pepper Lane"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Reading Scientific Serices Ltd"
},
"contactPoint": {
"telephone": "+44 0118918400"
},
"additionalContactPoints": [
{
"faxNumber": "+44 0118918400",
"telephone": "+44 0118918400"
}
]
},
{
"id": "GB-FTS-148960",
"name": "Wickham Micro Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Gosport",
"postalCode": "PO130AU",
"countryName": "United Kingdom",
"streetAddress": "Hoeford Point, Barwell Lane"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Wickham Micro Ltd"
},
"contactPoint": {
"telephone": "+44 7975959256"
}
},
{
"id": "GB-FTS-148961",
"name": "Assured Micro",
"roles": [
"supplier"
],
"address": {
"region": "UKM82",
"locality": "Glasgow",
"postalCode": "G20 0SP",
"countryName": "United Kingdom",
"streetAddress": "Block 6 Kelvin Campus, West Scotland Science Park"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "Assured Micro"
},
"contactPoint": {
"telephone": "+44 1419464545"
}
},
{
"id": "GB-FTS-148962",
"name": "CatSci Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKL22",
"locality": "Cardiff",
"postalCode": "CF64 5TH",
"countryName": "United Kingdom",
"streetAddress": "CBTC2, CBTC2, Capital Business Park, Wentloog,"
},
"details": {
"scale": "sme"
},
"identifier": {
"legalName": "CatSci Ltd"
},
"contactPoint": {
"telephone": "+44 7799286698"
}
},
{
"id": "GB-FTS-78625",
"name": "Glasgow Sheriff & Justice of the Peace Court",
"roles": [
"reviewBody"
],
"address": {
"locality": "Glasgow",
"postalCode": "G5 9DA",
"countryName": "United Kingdom",
"streetAddress": "Sheriff Clerk's Office, 1 Carlton Place"
},
"identifier": {
"legalName": "Glasgow Sheriff & Justice of the Peace Court"
}
}
],
"language": "en",
"contracts": [
{
"id": "024445-2025-1",
"title": "Water Testing (Glasgow Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-1",
"dateSigned": "2025-03-04T00:00:00Z"
},
{
"id": "024445-2025-2",
"title": "RNA Therapeutic/Vaccines",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-2",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-3",
"title": "Recombinant Protein Therapeutics",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-3",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-4",
"title": "Process and Product Microbiology (Teesside Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-4",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-5",
"title": "Process and Product Microbiology (Glasgow Area)",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-5",
"dateSigned": "2025-04-28T00:00:00+01:00"
},
{
"id": "024445-2025-6",
"title": "Oligonucleotides",
"value": {
"amount": 1000000,
"currency": "GBP"
},
"status": "active",
"awardID": "024445-2025-6",
"dateSigned": "2025-04-28T00:00:00+01:00"
}
],
"description": "(SC Ref:797494)",
"initiationType": "tender"
}12 Aug 2024 · 025441-2024 · tender
{
"id": "025441-2024",
"tag": [
"tender"
],
"date": "2024-08-12T14:35:16+01:00",
"ocid": "ocds-h6vhtk-0489eb",
"buyer": {
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774949"
}
],
"tender": {
"id": "3345",
"lots": [
{
"id": "1",
"title": "Water Testing (Glasgow Area)",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "The MMIC facility near Glasgow will require microbiological testing of water samples in accordance with Ph. Eur. [0169]. The following analysis techniques are required and have been included in pricing schedule for comparison:\n-Microbiological monitoring (Ph. Eur.)\n-Bacterial endotoxin testing (Ph. Eur.)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
},
{
"id": "2",
"title": "RNA Therapeutic/Vaccines",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Our facility in Darlington currently manufactures RNA-LNP vaccines and therapeutics for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for RNA-LNP analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for RNA In-process samples, RNA-LNP drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for RNA-LNP drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "- Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
},
{
"id": "3",
"title": "Recombinant Protein Therapeutics",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Our facility in Darlington will, in the future, manufacture Recombinant protein vaccines and therapeutics produced in Microbial cell lines, for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations.\nThe requirements for Recombinant Protein analysis include:\n-\tMethod development, verification and Phase appropriate validation (as required)\n-\tIntegrity analysis for Recombinant Protein drug substance and drug product (release and stability analysis)\n-\tProcess impurity testing for Recombinant Protein drug substance and drug product",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
},
{
"id": "4",
"title": "Process and Product Microbiology (Teesside Area)",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Our facility in Darlington will require Microbiology testing to support the RNA-LNP and Recombinant Protein GMP manufacture.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Buffers)\n-\tEndotoxin (Process product Protein)\n-\tEndotoxin (Process product RNA and RNA-LNP)\n-\tBioburden (Buffers)\n-\tBioburden (Process product Protein)\n-\tBioburden (Process product RNA and RNA-LNP)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
},
{
"id": "5",
"title": "Process and Product Microbiology (Glasgow Area)",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Our facility in Glasgow will require Microbiology testing to support the GMP manufacturing of oligonucleotide therapies.\nThe following analysis is required, all under Ph.Eur:\n-\tEndotoxin (Process product oligonucleotide)\n-\tBioburden (Process product oligonucleotide)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
},
{
"id": "6",
"title": "Oligonucleotides",
"status": "active",
"renewal": {
"description": "48 months with 1 additional 12 months period extension options\nat the discretion of the Authority."
},
"hasOptions": false,
"hasRenewal": true,
"description": "The facility at MMIC will manufacture both single and double stranded novel oligonucleotides for early phase clinical trials. The drug substance (API) may be a lyophilised powder or solution API and the finished drug product may be a solid or liquid formulation.\nThe requirements for oligonucleotides analysis include:\n-\tChemical analysis for oligonucleotide drug substance and drug product (release and stability analysis)\n-\tMethod development, verification and phase appropriate validation (as required)",
"awardCriteria": {
"criteria": [
{
"name": "GMP Questionnaire",
"type": "quality",
"description": "5"
},
{
"name": "Technical Specification",
"type": "quality",
"description": "20"
},
{
"name": "Turnaround timescales (Lead Time)",
"type": "quality",
"description": "20"
},
{
"name": "Qualification and Experience",
"type": "quality",
"description": "20"
},
{
"name": "Order Processing, Account Management & Customer Service",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "30"
}
]
},
"contractPeriod": {
"durationInDays": 1440
},
"submissionTerms": {
"variantPolicy": "allowed"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
},
{
"id": "6",
"relatedLot": "6",
"deliveryAddresses": [
{
"region": "UKM83"
}
],
"additionalClassifications": [
{
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
}
]
}
],
"title": "Framework for QC Analytical Testing Requirements",
"status": "active",
"coveredBy": [
"GPA"
],
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
}
],
"bidOpening": {
"date": "2024-09-12T12:00:00+01:00"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lotDetails": {
"maximumLotsBidPerSupplier": 6
},
"techniques": {
"frameworkAgreement": {
"maximumParticipants": 3
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"startDate": "2024-09-12T12:00:00+01:00"
},
"description": "You are invited to submit a tender for the following requirements; analytical services for multiple modalities drug substances and drug products required for early phase clinical trials. This tender is to cover the analytical services required for release analysis of drug substance (DS) and drug product (DP).",
"tenderPeriod": {
"endDate": "2024-09-12T12:00:00+01:00"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"hasRecurrence": false,
"classification": {
"id": "71620000",
"scheme": "CPV",
"description": "Analysis services"
},
"submissionTerms": {
"languages": [
"en"
]
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"mainProcurementCategory": "services",
"submissionMethodDetails": "https://in-tendhost.co.uk/uk-cpi/aspx/Home",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-3317",
"name": "Centre for Process Innovation Limited",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UK",
"locality": "Redcar",
"postalCode": "TS10 4RF",
"countryName": "United Kingdom",
"streetAddress": "Wilton Centre"
},
"details": {
"url": "http://www.uk-cpi.com",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA30305",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"description": "Research And Development"
}
]
},
"identifier": {
"legalName": "Centre for Process Innovation Limited"
},
"contactPoint": {
"url": "https://in-tendhost.co.uk/uk-cpi/aspx/Home",
"name": "E-Tendering",
"email": "e-tendering@uk-cpi.com",
"telephone": "+44 1642455340"
}
},
{
"id": "GB-FTS-78625",
"name": "Glasgow Sheriff & Justice of the Peace Court",
"roles": [
"reviewBody"
],
"address": {
"locality": "Glasgow",
"postalCode": "G5 9DA",
"countryName": "United Kingdom",
"streetAddress": "Sheriff Clerk's Office, 1 Carlton Place"
},
"identifier": {
"legalName": "Glasgow Sheriff & Justice of the Peace Court"
}
}
],
"language": "en",
"description": "NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=774949.\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nThrough research and development\n(SC Ref:774949)",
"initiationType": "tender"
}